Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.79M | -1.53M | -2.26M | -1.29M | -1.30M |
| Total Depreciation and Amortization | 98.80K | 96.10K | 93.10K | 91.20K | 89.60K |
| Total Amortization of Deferred Charges | 231.40K | 184.50K | 153.80K | 134.10K | 131.90K |
| Total Other Non-Cash Items | 359.20K | 360.10K | 1.20M | 243.60K | 235.60K |
| Change in Net Operating Assets | -22.20K | 33.40K | 162.90K | 392.80K | 408.90K |
| Cash from Operations | -1.12M | -852.50K | -657.70K | -423.90K | -431.90K |
| Capital Expenditure | -26.10K | -26.10K | -26.10K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 83.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.70K | 17.30K | 41.30K | 41.30K | 33.00K |
| Cash from Investing | -42.80K | -8.80K | 15.20K | 41.30K | 116.60K |
| Total Debt Issued | 1.73M | 1.57M | 1.24M | 971.90K | 832.00K |
| Total Debt Repaid | -558.80K | -630.20K | -584.00K | -552.70K | -516.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.17M | 940.40K | 656.40K | 419.10K | 315.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.50K | 79.00K | 13.80K | 36.40K | -- |